RxDoctor Payments Data

Jason Kline, DPM

Podiatrist · Newark, DENPI 1437191475

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,382 of the $8,612 with a category attached, or 85.7%. 11 manufacturers reported payments, led by Smith+Nephew at 46.9% of the total. Among podiatrist clinicians in DE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,612in general payments, 2019–2025

Across 110 payments — averaging $78.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$4K
  • Ossio Inc$2K
  • Stryker$956
  • Osteomed LLC$716
  • Treace Medical Concepts, Inc.$289
  • Acera Surgical, Inc.$224
  • plus $408 from 5 others

What the payments were for

  • Travel & lodging$7909%
  • Food & beverage$7,38286%
  • Education$4405%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew58$4,039
Ossio Inc2$1,980
Stryker(2 entities)13$956
Osteomed LLC20$716
Treace Medical Concepts, Inc.4$289
Acera Surgical, Inc.4$224
Novartis1$124
Bioventus LLC2$96
Paratek Pharmaceuticals, Inc.4$76
Keswick Pharmaceuticals LLC1$59
Organogenesis Inc.1$53

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,612 in reported general payments places this provider in the 90th percentile of 37 podiatrist providers in Delaware.

See all podiatrist providers in Delaware

Medicare billing

Part B allowed, 2024
$123,540
Medicare patients
427
Services billed
2,108

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole82$2,379
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen76$849
Gabapentin38$531
Cephalexin20$405
Ammonium Lactate17$306
Ibuprofen28$239
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen28$154
Methylprednisolone28$153

Paid to pharmacies, not to this prescriber.

Other podiatrist in Newark

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →